Patrick J. Kiel, PharmD

Adjunct Clinical Associate Professor of Medicine
Indiana University School of Medicine
Indianapolis, Indiana, United States

Disclosure(s): Amgen: Employee, Stocks/Bonds (Public Company)

Presentation(s):

• 211 - Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice

  Thursday, October 17, 2024
  4:15 PM – 4:30 PM US PT